Skip to content

Clinical trials

Observational Carcinoma, Hepatocellular trials in Sweden

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Phase: Observational Country / region: Sweden Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20091
20131
20151
20171
20213
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting5

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer2
Eisai Inc.1
Karolinska Institutet1
Linkoeping University1
Maastricht University Medical Center1
Mattias Ekstedt1
National Cancer Institute (NCI)1
Newcastle University1
Region Skane1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular10
Liver Cirrhosis3
Cholangiocarcinoma2
Hepatitis C2
Sarcopenia2
Acquired Immunodeficiency Syndrome1
Bile Duct Neoplasms1
Cardiovascular Diseases1
Diabetes Mellitus, Type 21
Dyslipidemias1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.